BeyondSpring (BYSI) Enterprise Value (QoQ) (2016 - 2026)
BeyondSpring (BYSI) Enterprise Value (QoQ) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.60 Bn | 130.75 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.93 Bn | 77.93 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.06 Bn | 59.88 Bn | 1.37 Bn |
| 4 | Moderna | 56.22 Bn | 51.08 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.03 Bn | 36.93 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.65 Bn | 28.34 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.70 Bn | 9.31 Bn | 668.28 Mn |
| 8 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.31 Bn | 26.48 Bn | - |
| 10 | BeyondSpring | 30.64 Mn | 30.64 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -190.08% |
| Mar 31, 2026 | 15.03% |
| Dec 31, 2025 | -471.61% |
| Sep 30, 2025 | -126.74% |
| Jun 30, 2025 | -59.63% |
| Mar 31, 2025 | -53.96% |
| Dec 31, 2021 | 41.51% |
| Sep 30, 2021 | -61.03% |
| Jun 30, 2021 | 20.00% |
| Mar 31, 2021 | 17.65% |
| Dec 31, 2020 | -196.91% |
| Sep 30, 2020 | 15.38% |
| Jun 30, 2020 | -48.03% |
| Mar 31, 2020 | 28.32% |
| Dec 31, 2019 | -44.10% |
| Sep 30, 2019 | -671.24% |
| Jun 30, 2019 | 30.24% |
| Mar 31, 2019 | 22.28% |
| Dec 31, 2018 | 47.71% |
| Sep 30, 2018 | 42.93% |